[The role of transfusions in post-operative cytomegalovirus infections (in non-immunosuppressed subjects)].
Cytomegalovirus (CMV) infection is most frequently observed after open heart surgery with extracorporeal circulation (ECC) and common after thoracic surgery without ECC and after splenectomies though very rare after other types of surgery. Studies on open heart patients with ECC carried out in the period 1968-1979 show an average seroconversion rate of 28% while the febrile mononucleosis syndrome rate would amount to 4.2%. Seroconversion is defined as a confirmed increase in the titer of complement fixing (CF) antibody by a factor of 4 or more. The risk of CMV infection is proportional to the quantity of blood transfused. Fresh blood was initially suspected of being the cause, but later investigator have found no difference between fresh and preserved blood. Seroconversion and/or infection risks can be sharply cut by using deleukocyted blood or frozen deglycerolized erythrocytes free of viable leukocytes. Seroconversion risk increases significantly when CMV (CF) antibodies are present in transfused blood. However, the presence of these antibodies in the recipient's blood appears to afford protection against seroconversion and/or infection, except in the case of immunodepressed patients. In conclusion, CMV febrile mononucleosis syndrome might be due to latent CMV in the transfused blood. This transfusion of allogenic blood might induce an immunological reaction that reactivates the latent CMV transmitted to recipient.
D000914:Antibodies, Viral / Q000032:analysis; D001793:Blood Preservation; D006348:Cardiac Surgical Procedures / Q000009:adverse effects; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000209:etiology* / Q000276:immunology; D005112:Extracorporeal Circulation / Q000009:adverse effects; D006801:Humans; D007165:Immunosuppression Therapy; D011183:Postoperative Complications; D012306:Risk; D013156:Splenectomy / Q000009:adverse effects; D065227:Transfusion Reaction; D014775:Virus Activation
D000914:Antibodies, Viral
Rôle des transfusions au cours des infections à cytomégalovirus post-chirurgicales (chez des sujets non immunodéprimés).